BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 24387826)

  • 1. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
    Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
    Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
    Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
    Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns--correlation study with contrast-enhanced CT.
    Zhou X; Luo Y; Peng YL; Cai W; Lu Q; Lin L; Sha XX; Li YZ; Zhu M
    Radiology; 2011 Jul; 260(1):274-81. PubMed ID: 21467250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
    Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
    Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
    Quaia E
    Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
    D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
    J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions.
    Corvino A; Catalano O; Corvino F; Sandomenico F; Petrillo A
    AJR Am J Roentgenol; 2017 Sep; 209(3):W119-W127. PubMed ID: 28639831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography.
    Bartolotta TV; Taibbi A; Midiri M; Matranga D; Solbiati L; Lagalla R
    Invest Radiol; 2011 Feb; 46(2):106-15. PubMed ID: 20938345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis.
    Rahbin N; Siösteen AK; Elvin A; Blomqvist L; Hagen K; Hultcrantz R; Aleman S
    Acta Radiol; 2008 Apr; 49(3):251-7. PubMed ID: 18365808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
    Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
    Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
    Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
    Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
    J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
    Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.